Sorry, you need to enable JavaScript to visit this website.

Greenstone LLC Introduces 12 Generic Products to Date in 2011

Peapack, NJ; October 2011 — Through just the first nine months of 2011, Greenstone LLC, the generic pharmaceutical subsidiary of Pfizer Inc., has expanded its line of product offerings by introducing 12 additional generics, bringing the company’s current portfolio to more than 80 generic medicines.

Among this group of 12 new products are the following:

  • Diphenoxylate Hydrochloride and Atropine Sulfate Tablets
  • Exemestane Tablets
  • Famciclovir Tablets
  • Gabapentin Oral Solution
  • Galantamine Tablets
  • Latanoprost Sterile Ophthalmic Solution
  • Voriconazole Tablets

As anticipated, the portfolio of products offered by Greenstone continues to expand, with a combination of ANDAs and Authorized Generics.

Each product in the Greenstone portfolio is supported by the company’s long-standing commitment to quality, reliable manufacturing, and customer-centric attention.